Johnson And Johnson Covid Vaccine
-
{
- All
- News
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
- Saturday October 16, 2021
- World News | Agence France-Presse
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
www.ndtv.com
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
- Friday August 20, 2021
- India News | Reported by Parimal Kumar, Edited by Chandrashekar Srinivasan
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
www.ndtv.com
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
- Monday August 2, 2021
- India News | Reuters
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
www.ndtv.com
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
- Saturday October 16, 2021
- World News | Agence France-Presse
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
www.ndtv.com
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
- Friday August 20, 2021
- India News | Reported by Parimal Kumar, Edited by Chandrashekar Srinivasan
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
www.ndtv.com
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
- Monday August 2, 2021
- India News | Reuters
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
www.ndtv.com